| Price | 137.50p on 08-08-2025 at 12:50:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 140.00p |
| Sell | 135.00p |
| Last Trade: | Buy 871.00 at 137.70p |
| Day's Volume: | 19,289 |
| Last Close: | 137.50p |
| Open: | 137.50p |
| ISIN: | GB00BJQTGV64 |
| Day's Range | 137.50p - 137.50p |
| 52wk Range: | 107.50p - 151.00p |
| Market Capitalisation: | £116.25m |
| VWAP: | 137.4306p |
| Shares in Issue: | 84.55m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Diaceutics (DXRX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 871 | 137.70p | Ordinary |
13:14:39 - 08-Aug-25 |
| Buy* | 5,000 | 137.70p | Ordinary |
13:13:53 - 08-Aug-25 |
| Sell* | 5,000 | 137.125p | Ordinary |
12:16:00 - 08-Aug-25 |
| Sell* | 3,869 | 137.10p | Ordinary |
12:07:06 - 08-Aug-25 |
| Buy* | 4,000 | 137.70p | Ordinary |
11:53:37 - 08-Aug-25 |
| Buy* | 549 | 137.70p | Ordinary |
08:59:39 - 08-Aug-25 |
| Unknown* | 100,000 | 137.50p | Negotiated Trade |
16:46:49 - 07-Aug-25 |
| Buy* | 14 | 140.00p | SI Trade |
14:28:13 - 07-Aug-25 |
| Buy* | 43 | 140.00p | SI Trade |
14:28:13 - 07-Aug-25 |
| Buy* | 7 | 140.00p | SI Trade |
14:28:13 - 07-Aug-25 |
Diaceutics (DXRX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th Aug 2025 7:00 am | RNS-R | Diaceutics at Canaccord Genuity Growth Conference |
| 30th Jul 2025 7:00 am | RNS | PDMR Shareholding/Share Incentive Plan and TVR |
| 29th Jul 2025 7:00 am | RNS-R | Diaceutics Announces Key Leadership Appointment |
| 25th Jul 2025 12:15 pm | RNS | Holding(s) in Company |
| 23rd Jul 2025 7:00 am | RNS | Issue of Share Options / PDMR Shareholdings |
| 22nd Jul 2025 7:00 am | RNS | 22% Revenue Growth H125 representing 3-yr CAGR 25% |
| 17th Jul 2025 7:00 am | RNS-R | Expansion of PMx Commercialization Partnership |
| 30th Jun 2025 7:00 am | RNS | PDMR Shareholding/SIP and Total Voting Rights |
| 18th Jun 2025 12:00 pm | RNS | Results of AGM |
| 6th Jun 2025 9:33 am | RNS | PDMR Shareholding /Share Incentive Plan and TVR |
